New Extramural Funding

Updated: January 16, 2019

Following is a list of the most recently announced cancer-focused extramural funding opportunities. Please refer to our Upcoming Funding page for additional funding opportunities.

 

National Institutes of Health

NIH Research Evaluation and Commercialization Hub (REACH) Awards (U01 Clinical Trial Not Allowed)  — Application Deadline: 1/23/19

Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trial Not Allowed) — Application Deadline: 1/24/19

Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) — Application Deadline: 2/5/19

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) — Application Deadline: 2/5/19

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional) — Application Deadline: 2/5/19

Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) — Application Deadline: 2/5/19

Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional) — Application Deadline: 2/5/19

Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional) — Application Deadline: 2/5/19

Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional) — Application Deadline: 2/5/19

Secondary Analyses of Alcohol and Chronic Disease (R01) — Application Deadline: 2/5/19

Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01 Clinical Trial Not Allowed) — Application Deadline: 2/8/19

Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01 Clinical Trial Not Allowed) — Application Deadline: 2/8/19

Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (UG3/UH3 Clinical Trials Not Allowed) — Application Deadline: 2/11/19

Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers (U54 Clinical Trial Not Allowed) — Application Deadline: 2/11/19

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) — Application Deadline: 2/11/19

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) — Application Deadline: 2/12/19

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required) — Application Deadline: 2/12/19

Mentored Patient-Oriented Research Career Development Award (Parent K23 – Independent Clinical Trial Not Allowed) — Application Deadline: 2/12/19

NIH Pathway to Independence Award (Parent K99/R00 – Independent Clinical Trial Not Allowed) — Application Deadline: 2/12/19

NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) — Application Deadline: 2/12/19

Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required) — Application Deadline: 2/12/19

Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional) — Application Deadline: 2/16/19

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional) — Application Deadline: 2/16/19

Secondary Analyses of Alcohol and Chronic Disease (R03) — Application Deadline: 2/16/19

Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional) — Application Deadline: 2/16/19

Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) — Application Deadline: 2/21/19

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) — Application Deadline: 2/25/19

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) — Application Deadline: 2/25/19

NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Not Allowed) — Application Deadline: 2/26/19

NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required) — Application Deadline: 2/26/19

Limited Competition: Lasker Clinical Research Scholars Transition Award (R00) — Application Deadline: Rolling Dates

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp – Clinical Trial Not Allowed) — Application Deadline: Rolling Dates

 

American Institute for Cancer Research

Cancer Research Grant Program— Application Deadline: 1/25/19

 

Merck

Pembrolizumab Funding Review Cycle — Application Deadline: 1/25/19

 

Florida Breast Cancer Foundation

Request for Scientific Grant Applications — Application Deadline: 1/28/19

Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families — Application Deadline: 1/28/19

 

Patient-Centered Outcomes Research Institute

Engagement Award: Dissemination Initiatives — LOI Deadline: 2/1/19

Engagement Award: Conference Support — LOI Deadline: 2/1/19

Engagement Award: Capacity Building — LOI Deadline: 2/1/19

 

Jane Coffin Childs Memorial Fund for Medical Research

Cancer Research Fellowships — Application Deadline: 2/1/19